HIV-positive individuals are at higher risk of Methicillin Resistant
Staphylococcus aureus (MRSA) colonization and
its related infection. There is limited data in the nation on the prevalence and
risk factors of MRSA colonization among HIV patients. The aim of this study was to
address the existing knowledge gap. Cross sectional study was carried out from
September 2014 to February 2015 in three selected health centers and one general
hospital. A standardized questionnaire was developed for collection of
socio-demographic and clinical data. A total of 498 Nasal and throat swabs (two for
each patient) were collected from 249 patients, transported and processed using
standard bacteriological procedures. Data was analyzed using Chi square
(X2) test and associated risk factors were determined.
P < 0.05 was considered statistically
significant. Out of 249 study participants, S.
aureus was isolated from 81 (32.5 %) patients, with MRSA colonization
rate of 6 (2.4 %). MRSA isolates were resistant to Ciprofloxacin and
trimethoprim-sulphamethoxazole (16.7 % each), clindamycin (33.3 %) and erythromycin
(50 %). However, all MRSA isolates were 100 % sensitive to Amikacin. History of
hospitalization, percutaneous device usage, patients with a household member’s
hospitalization and low CD4 count (<200
cells/mm3) were significantly associated with S. aureus colonization (p < 0.05).